Interventions are actions taken by or for individuals to reduce the risk, duration, or severity of adverse health conditions. Interventions may be population-based or personal.
DCP2 and GBD present what we know about which health interventions work for a comprehensive range of diseases, injuries, and disabilities in many different contexts. A large share of the disease burden in low- and middle-income countries is attributable to diseases and conditions for which cost-effective interventions are already known and feasible. Selecting the right intervention for a given disease and context matters a great deal. The tools on this page are designed to aid the task.
DCP2 and GBD demonstrate how decision makers could use cost-effectiveness information in combination with information on disease prevalence and avertable illness to determine which interventions should be extended and which ones should be questioned. If developing countries scale up interventions and extend health care services that are cost-effective, the impact on the disease burden could be substantial.
Download Results (CSV)
|
Download Full Data Set (XLS)
| Condition |
Intervention
|
Intervention type
|
Intervention description |
Intervention setting
|
Objective
|
Target population
|
Cost effectiveness
(US$/DALY)
|
Cost effectiveness estimate
(US$)
|
Cost effectiveness range
(US$/DALY)
|
Number of DALYs averted
(hundreds)
|
Number of deaths averted
(hundreds)
|
Quality of cost-effectiveness analysis evidence
|
|
Opioid abuse
|
Buprenorphine maintenance substitution |
Personal |
Buprenorphine substitution maintenance treatment for non-methadone patients. |
Clinic
|
rehabilitation
|
Adults, Women of childbearing age
|
- |
49,000 per QALY (Highincome countries) |
- |
- |
- |
1 |
|
Opioid abuse
|
Conventional outpatient detoxification |
Personal |
Conventional outpatient detoxification is supervised withdrawal from a drug of dependence that attempts to minimize withdrawal symptoms. |
Clinic
|
rehabilitation
|
Adults, Women of childbearing age
|
- |
12,764 per abstinent patient (Australia) |
- |
- |
- |
1 |
|
Opioid abuse
|
Drug-free treatments |
Personal |
Residential or outpatient drug-free treatments as well as self-help group attendance |
Clinic
|
rehabilitation
|
Adults, Women of childbearing age
|
- |
7000-13,000a (USA) |
- |
- |
- |
1 |
|
Opioid abuse
|
Methadone maintenance substitution |
Personal |
Substitution of short-acting heroin with long-acting orally administered opioid Methodone; includes heroin users living in communities with high HIV prevalence |
Clinic
|
rehabilitation
|
Adults, Women of childbearing age
|
- |
6800 per LYS (Highincome countries); 9000 per QALY (High-income countries, high-HIV prevalence) |
- |
- |
- |
1 |
|
Opioid abuse
|
Naltrexone induced rapid opioid detoxification under sedation (RODS) |
Personal |
Patient is given naltrexone under general anesthetic. |
Local or district hospital
|
rehabilitation
|
Adults, Women of childbearing age
|
- |
2,498 per week of abstinence (Australia) |
- |
- |
- |
1 |
Download Results (CSV)
|
Download Full Data Set (XLS)